Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × OTHER × Patient Preference × Clear all

Phase

Status

Completed 9 Recruiting 2 Withdrawn 1 Unknown 1 Terminated 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 286 Neoplasms 186 Prostatic Neoplasms 170 Carcinoma, Non-Small-Cell Lung 130 Lung Neoplasms 107 Pancreatic Neoplasms 97 Colorectal Neoplasms 96 Neoplasm Metastasis 82 Carcinoma, Hepatocellular 81 Leukemia, Myeloid, Acute 79 Brain Neoplasms 76 Multiple Myeloma 74 Head and Neck Neoplasms 71 Lymphoma 67 Melanoma 64 Ovarian Neoplasms 62 Glioblastoma 60 Leukemia 58 Leukemia, Lymphocytic, Chronic, B-Cell 55 Colonic Neoplasms 55 Precursor Cell Lymphoblastic Leukemia-Lymphoma 51 Recurrence 47 Rectal Neoplasms 46 Hematologic Neoplasms 43 Squamous Cell Carcinoma of Head and Neck 42 Glioma 42 Lymphoma, Non-Hodgkin 39 Lymphoma, Follicular 38 Carcinoma, Renal Cell 38 Sarcoma 35

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01906073 2020-12-10

NFCP-2

Norwegian University of Science and Technology

Phase 3 Withdrawn

Neoplasms, Pain, Patient Satisfaction, Patient Preference

Data powered by HemOnc (CC BY 4.0) Colophon ⚡